These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7554389)

  • 1. Signalling via CD28 of human naive neonatal T lymphocytes.
    Hassan J; O'Neill S; O'Neill LA; Pattison U; Reen DJ
    Clin Exp Immunol; 1995 Oct; 102(1):192-8. PubMed ID: 7554389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low CD3+CD28-induced interleukin-2 production correlates with decreased reactive oxygen intermediate formation in neonatal T cells.
    Kilpinen S; Hurme M
    Immunology; 1998 Jun; 94(2):167-72. PubMed ID: 9741337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accessory signalling by B7-1 for T cell activation induced by anti-CD2: evidence for IL-2-independent CTL generation and CsA-resistant cytokine production.
    Van Gool SW; Kasran A; Wallays G; de Boer M; Ceuppens JL
    Scand J Immunol; 1995 Jan; 41(1):23-30. PubMed ID: 7529939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
    Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
    J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation.
    Yang SY; Denning SM; Mizuno S; Dupont B; Haynes BF
    J Exp Med; 1988 Oct; 168(4):1457-68. PubMed ID: 3049912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-stimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency.
    North ME; Akbar AN; Borthwick N; Sagawa K; Funauchi M; Webster AD; Farrant J
    Clin Exp Immunol; 1994 Feb; 95(2):204-8. PubMed ID: 7905793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
    Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
    Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 augments the diminished interleukin-2 mRNA expression and proliferative response of neonatal T lymphocytes to anti-CD2 antibodies.
    Hassan J; Reen DJ
    Scand J Immunol; 1994 Jun; 39(6):597-601. PubMed ID: 7912004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other co-stimulatory molecules.
    Yashiro Y; Tai XG; Toyo-oka K; Park CS; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    Eur J Immunol; 1998 Mar; 28(3):926-35. PubMed ID: 9541588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic activity of anti-CD28 MoAb CLB-CD28/1 on peripheral blood mononuclear cells and its cooperation with other anti-T cells MoAb in the activation of purified T lymphocytes.
    De Felice M; Giarrusso PC; Lamberti A; Turco MC; Valerio G; van Lier RA; Yang SY; Ferrone S; Venuta S
    Tissue Antigens; 1990 Jul; 36(1):12-8. PubMed ID: 1701062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
    Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective induction of interleukin-4- and interferon-y-producing T cells from cord blood naive T cells. Effects of costimulatory signaling through CD28.
    Katamura K; Tabata Y; Oshima Y; Shintaku N; Yamauchi Y; Mayumi M
    Int Arch Allergy Immunol; 1995 Feb; 106(2):101-6. PubMed ID: 7819736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct mechanisms of interleukin-2 gene expression in human T lymphocytes.
    June CH; Jackson KM; Ledbetter JA; Leiden JM; Lindsten T; Thompson CB
    J Autoimmun; 1989 Jun; 2 Suppl():55-65. PubMed ID: 2550020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells.
    Schmidt-Weber CB; Wohlfahrt JG; Akdis CA; Blaser K
    Eur J Immunol; 2002 Apr; 32(4):1196-204. PubMed ID: 11932928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription.
    Sanchez-Lockhart M; Miller J
    J Immunol; 2006 Apr; 176(8):4778-84. PubMed ID: 16585571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD2-CD48 interactions promote interleukin-2 and interferon-gamma synthesis by stabilizing cytokine mRNA.
    Musgrave BL; Watson CL; Haeryfar SM; Barnes CA; Hoskin DW
    Cell Immunol; 2004 May; 229(1):1-12. PubMed ID: 15331323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency.
    Fischer MB; Wolf HM; Eggenbauer H; Thon V; Vogel E; Lokaj J; Litzman J; Mannhalter JW; Eibl MM
    Clin Exp Immunol; 1994 Feb; 95(2):209-14. PubMed ID: 8306493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
    Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
    Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction.
    Horwitz DA; Tang FL; Stimmler MM; Oki A; Gray JD
    Arthritis Rheum; 1997 May; 40(5):822-33. PubMed ID: 9153542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.